Terumo corporation

Corporate registers are an essential tool for businesses to keep track of their legal and financial information. They help ensure that companies are compliant with regulations and ...

Terumo corporation. Apr 30, 2024 ... Terumo Corporation: Enhancing Patient Accessibility for Blood and Cell Therapies. See how Terumo is working to increasing patient access ...

Terumo Cardiovascular Systems Corporation, headquartered in Michigan, handles the research, development, and production of Cardiovascular Business products. Headquartered on the West Coast in California, MicroVention Inc. develops, manufactures, and sells the neurovascular treatment devices of the Neurovascular Business.

Terumo Medical Corporation (TMC) is always striving to help healthcare providers take advantage of the latest medical innovations. This includes supporting Investigator-Initiated Studies (IIS), studies that require investigators and/or their institutions to fulfill the responsibility of sponsors. Sep 21, 2017 ... Terumo Corporation named exclusive distributor for ivWatch in Japan, licenses ivWatch IV infiltration detection technology for use in its ...Terumo Corporation (TSE: 4543) is celebrating its 100 th anniversary this year - marking 100 years of 'Contributing to Society through Healthcare' on September 17, 2021. The company has established 'Stride Ahead' as a slogan, to celebrate and connect all Terumo associates around the world. The phrase encompasses the company's belief …Corporate Terumo Blood and Cell Technologies partners with CiRA Foundation to develop automated iPS cell manufacturing iPS cell manufacturing organization researchers to integrate Terumo Blood and Cell Technologies’ Quantum Flex, expertise through collaboration$30 million investment further demonstrates Terumo’s commitment to its global healthcare provider customers and their patients. Local operations employs 340 associates. SOMERSET, NJ and CAGUAS, PR – February 14, 2024 – Terumo Medical Corporation (TMC) broke ground recently on a new manufacturing facility at its Caguas, Puerto Rico site.TOKYO, JAPAN and PARIS, FRANCE - November 17, 2021 - Terumo Corporation, a global leader in medical technology and the French company Diabeloop, a pioneer in therapeutic AI, announced today that they have signed an agreement for a comprehensive strategic partnership.In the competitive world of business, having a well-defined sales strategy is crucial for success. Whether you’re a small start-up or a large corporation, there are various sale st...Advertisement Your final option for operating your LLC is to run it as an S corporation, which you can do if your business has multiple owners/shareholders, although not more than ...

This logo image consists only of simple geometric shapes or text. It does not meet the threshold of originality needed for copyright protection, and is ...Terumo Blood and Cell Technologies. Terumo Blood & Cell Technologies (TerumoBCT) is a part of global leading company PT Terumo Indonesia with aspiration “Unlocking the Potential of Blood”. TerumoBCT provides various of instruments supporting safety & efficiency of blood donation, blood components production, as well as cell therapy. View ...Terumo Medical Corporation is a leading manufacturer of medical devices and supplies, with a global presence in more than 160 countries. Learn about its products, services, …Terumo Corporation was founded in 1921 by several scientists and doctors, including Dr. Shibasaburo Kitasato, to produce clinical thermometers in Japan. ... Each device offered by Terumo Medical Products is designed to help clinicians deliver the very best care to their patients. In an industry already known for its high quality standards, we ...Apr 30, 2024 ... Terumo Corporation: Enhancing Patient Accessibility for Blood and Cell Therapies. See how Terumo is working to increasing patient access ...Terumo's Response to COVID-19. Education and Training. Business Overview. Business Overview. TIS Division (Terumo Interventional Systems) Neurovascular Division (MicroVention) Cardiovascular Division (Terumo Cardiovascular)/ HeartSheet Division. Vascular Graft Division (Terumo Aortic) Hospital Care Solutions Division.Terumo Latin America Corporation | 3,935 followers on LinkedIn. At Terumo, we are committed to our Core Values: Respect. Integrity. Care. Quality. Creativity. | Terumo was founded in 1921 with the ...PUSHING BOUNDARIES IN INTERVENTIONAL MEDICINE. Terumo Interventional Systems (TIS), a division of Terumo Medical Corporation, is a market leader in minimally invasive entry site management, lesion access, and interventional technologies.

Total Integrated Fit (TIF) tip tapering: tapering design at the tip of the sheath and dilator to facilitate smooth penetration. Cross-cut hemostasis valve: to avoid blood reflux and air aspiration. Thin radiopaque sheath with anti-kinking sleeve: for easy catheter handling. Snap-on / click-off dilator lock: prevents dilator back-out during ...Terumo Corporation is a manufacturer and supplier of pharmaceuticals and medical tools and equipment. The Company's products include health foods, transfusion and infusion equipment, disposable ...Terumo's Response to COVID-19. Education and Training. Business Overview. Business Overview. TIS Division (Terumo Interventional Systems) Neurovascular Division (MicroVention) Cardiovascular Division (Terumo Cardiovascular)/ HeartSheet Division. Vascular Graft Division (Terumo Aortic) Hospital Care Solutions Division.RF 2FWGRJY–Smartphone with logo of Japanese medical equipment manufacturer Terumo Corp on screen in front of website. Focus on center-right of phone display.Terumo Russia. Контакты. ООО "Терумо Рус" Бизнес-центр "Северная Башня" ул.Тестовская , д. 10, 2-й подъезд, 13-й этаж Москва, 123112 Россия Тел. +7 (495) 988 4740 [email protected]. Send us a message. First name *. Last name *. Function. Company ...

Raleigh to miami.

80 Corporate Information Editorial Policy Terumo prepares communication tools to provide stakeholders with straightforward reporting on the business activities it is pursuing in fulfill - ment of its Group mission—“Contributing to Society through Healthcare”—and to promote communication with society. Terumo Reports provideLara Corporation is a leading global corporation that offers a wide range of business solutions to companies around the world. To begin using Lara Corporation’s online filing syste...Terumo Latin America Corporation | 3,935 followers on LinkedIn. At Terumo, we are committed to our Core Values: Respect. Integrity. Care. Quality. Creativity. | Terumo was founded in 1921 with the ...Terumo Corp (Terumo), manufactures and markets medical care products including hospital and medical products, and equipment. Its major product categories include pharmaceuticals, blood bags, disposable medical devices, nutritional food supplement, cardiovascular systems, vascular grafts, blood glucose monitoring system, medical …Medical Care Solutions Company. Blood and Cell Technologies Company. [ESG Section] (PDF 3.07 MB) Contents / Sustainability at the Terumo Group (PDF 308.01 KB) Environment (PDF 849.91 KB) EHS Management. Development of Environmentally Friendly and Safe Products. Initiatives to Address Climate Change.TOKYO, JAPAN – May 15, 2023 – Terumo Corporation (TSE: 4543) today announced that it will construct a new manufacturing facility for the Medical Care Solutions Company in the premises of the Kofu Factory located in Yamanashi, Japan. The total investment will be 52.2 billion JPY, and the construction will be completed in fiscal year 2025.

Terumo Medical Corporation (TMC) is always striving to help healthcare providers take advantage of the latest medical innovations. This includes supporting Investigator-Initiated Studies (IIS), studies that require investigators and/or their institutions to fulfill the responsibility of sponsors. While TMC may provide support or devices for a ...$30 million investment further demonstrates Terumo’s commitment to its global healthcare provider customers and their patients. Local operations employs 340 associates. SOMERSET, NJ and CAGUAS, PR – February 14, 2024 – Terumo Medical Corporation (TMC) broke ground recently on a new manufacturing facility at its Caguas, Puerto Rico site.In 2006, Terumo Corporation, a major worldwide medical device company headquartered in Tokyo, Japan, acquired MicroVention into their family of Companies. Terumo's acquisition of MicroVention allowed both Companies to leverage their unique, proprietary technologies toward an increased focus on treating cerebrovascular diseases.Terumo Corporation (TSE: 4543) is celebrating its 100 th anniversary this year - marking 100 years of 'Contributing to Society through Healthcare' on September 17, 2021. The company has established 'Stride Ahead' as a slogan, to celebrate and connect all Terumo associates around the world. The phrase encompasses the company's belief …Terumo Corporation press release (OTCPK:TRUMY): FY GAAP EPS of ¥71.47. Revenue totaled ¥921.9 billion, an increase of 12.4% versus the previous fiscal year.Terumo’s Purpose. Terumo's Response to COVID-19. Education and Training. Business Overview. Business Overview. TIS Division (Terumo Interventional Systems) Neurovascular Division (MicroVention) Cardiovascular Division (Terumo Cardiovascular)/ HeartSheet Division. Vascular Graft Division (Terumo Aortic)Business Overview. TIS Division (Terumo Interventional Systems) Neurovascular Division (MicroVention) Cardiovascular Division (Terumo Cardiovascular)/ HeartSheet Division. Vascular Graft Division (Terumo Aortic) Hospital Care Solutions Division. Life Care Solutions Division.Cell Therapy Technologies. By delivering solutions that automate cell therapy manufacturing, from cell expansion to final formulation, we partner with therapy developers to support the creation and commercialization of cutting-edge treatments. Cell expansion system. Cell therapy fill and finish system. Terumo Blood and Cell Technologies ...Jul 27, 2021 · TOKYO, JAPAN - July 27, 2021 - Terumo Corporation (TSE: 4543) announced today the launch of the Dexcom G6 continuous glucose monitoring (CGM) system in Japan. U.S. based Dexcom, Inc., manufactures the product, and Terumo holds the exclusive distribution agreement in Japan since their partnership in 2018. A CGM system is a medical device that ... Terumo Medical Corporation (TMC) is a subsidiary of Terumo Corporation, founded in 1972 as the United States expansion of our larger Tokyo-based parent. For over 50 years, TMC has continued the Terumo mission of offering the best possible solutions to healthcare providers and the people they serve.Terumo Russia. Контакты. ООО "Терумо Рус" Бизнес-центр "Северная Башня" ул.Тестовская , д. 10, 2-й подъезд, 13-й этаж Москва, 123112 Россия Тел. +7 (495) 988 4740 [email protected]. Send us a message. First name *. Last name *. Function. Company ...Terumo Medical Corporation (TMC) is always striving to help healthcare providers take advantage of the latest medical innovations. This includes supporting Investigator-Initiated Studies (IIS), studies that require investigators and/or their institutions to fulfill the responsibility of sponsors. While TMC may provide support or devices for a ...

One of these things is not like the other, one of these things is not like its brother. The US, UK, and Australia are in the midst of heated corporate tax debates right now. Conser...

San Diedo and Aliso Viejo, California – July 31, 2023 – MicroVention, Inc., a global neurovascular company and wholly owned subsidiary of Terumo Corporation, announced the publication of WEB-IT 5-year follow-up data and the addition of two sizes to its WEB Aneurysm Embolization System.With this five-year clinical trial data just recently …Advertisement Your final option for operating your LLC is to run it as an S corporation, which you can do if your business has multiple owners/shareholders, although not more than ... Company Description: Formed in 1921 to build a better thermometer, Terumo is one of Japan's largest health care product suppliers. The company makes and sells a wide range of general hospital products and equipment, including disposable supplies (syringes and wound dressings), blood glucose monitors, dialyzers, infusion pumps, and intravenous liquid nutrients. In 2006, Terumo Corporation, a major worldwide medical device company headquartered in Tokyo, Japan, acquired MicroVention into their family of Companies. Terumo's acquisition of MicroVention allowed both Companies to leverage their unique, proprietary technologies toward an increased focus on treating cerebrovascular diseases.Terumo's Purpose PUSHING BOUNDARIES IN INTERVENTIONAL MEDICINE Terumo Interventional Systems (TIS), a division of Terumo Medical Corporation, is a market leader in minimally invasive entry site management, lesion access, and interventional technologies. life at terumo medical corporation At TMC, we know that building a great environment goes beyond the workplace. Throughout the year, our Events and Activities Committee plans programs that bring employees together, including monthly birthday celebrations, company picnics, holiday parties for Associates and their children, Take Your Sons and ... $30 million investment further demonstrates Terumo’s commitment to its global healthcare provider customers and their patients. Local operations employs 340 associates. SOMERSET, NJ and CAGUAS, PR – February 14, 2024 – Terumo Medical Corporation (TMC) broke ground recently on a new manufacturing facility at its Caguas, Puerto Rico site.Terumo UK Ltd. markets and sells a wide range of quality products for angiography, cardiology and cardiovascular surgery, embolotherapy, infusion systems and injection. Terumo UK Ltd. was registered in 2003 and currently has 40 employees. Terumo UK Ltd. covers England, Scotland, Wales, Ireland and Northern Ireland.Technology. Terumo goes beyond boundaries—of R&D and production, of regions and functions, inside and outside the company—to further. evolve the technologies we have cultivated across decades and develop unprecedented new technologies. At the root of this work lies the Terumo Corporate Mission of Contributing to Society through Healthcare.Terumo Medical Pranex: Antoinette Gawin: Group Senior Managing Executive Officer: President, Blood and Cell Technologies Company President and CEO, Terumo BCT Holding Corp. Kazunori Hirose: Group Managing Executive Officer: In charge of Global Supply Chain, Quality and EHS; Quality, Post-Market Surveillance and Vigilance Division

Observer radio 91.1 fm antigua.

Seatac to las vegas.

Since 2012 Terumo has been committed to the UN Global Compact corporate responsibility initiative and its principles in the areas of human rights, labor, the environment, and anti-corruption. Terumo is a … Terumo Corporation (テルモ株式会社, Terumo Kabushiki-gaisha) was founded in 1921 as Red Line Thermometer Corporation by a group of medical scientists led by Dr. Kitasato Shibasaburō to produce medical thermometers in Japan. A subsidiary of Terumo Corporation, the “No. 1 Medical Device Manufacturer in Japan” with 20 factories and 79 sales branches supplying 150 countries globally. With the mission of contributing ...Terumo's Response to COVID-19. Education and Training. Business Overview. Business Overview. TIS Division (Terumo Interventional Systems) Neurovascular Division (MicroVention) Cardiovascular Division (Terumo Cardiovascular)/ HeartSheet Division. Vascular Graft Division (Terumo Aortic) Hospital Care Solutions Division.Terumo Deutschland GmbH Ludwig-Erhard-Straße 6 65760 Eschborn Deutschland. Allgemeine Anfragen. Tel: 06196 8023 0 Fax: 06196 8023 200 Email. Customer Service. Tel: 0800 1830042 Fax: 0800 1830043 Email. Zweigniederlassung Österreich Interventional Systems. Liebermannstrasse F10.301 2345 Brunn am GebirgeTerumo Medical Corporation's New AZUR HydroPack™ Peripheral Coil System Provides a Soft-Packing, Long-Lasting Solution to Embolotherapy – Enhances a comprehensive platform of AZUR™ hydrogel technologies with versatile and reliable packing for embolization – SOMERSET, N.J., Dec. 11, 2023 /PRNewswire/ -- Terumo …TOKYO, JAPAN - July 27, 2021 - Terumo Corporation (TSE: 4543) announced today the launch of the Dexcom G6 continuous glucose monitoring (CGM) system in Japan. U.S. based Dexcom, Inc., manufactures the product, and Terumo holds the exclusive distribution agreement in Japan since their partnership in 2018. A CGM system is a medical device …80 Corporate Information Editorial Policy Terumo prepares communication tools to provide stakeholders with straightforward reporting on the business activities it is pursuing in fulfill - ment of its Group mission—“Contributing to Society through Healthcare”—and to promote communication with society. Terumo Reports provide ….

In the “ 5-Year Growth Strategy with a 10-Year Vision ” (hereinafter, GS26) announced in December 2021, Terumo set a new innovation strategy vision called “From Devices to Solutions.”. Here is an introduction to the world Terumo aims for in the five years until FY2026 and the reason it is currently working toward this vision. Terumo's Response to COVID-19. Education and Training. Business Overview. Business Overview. TIS Division (Terumo Interventional Systems) Neurovascular Division (MicroVention) Cardiovascular Division (Terumo Cardiovascular)/ HeartSheet Division. Vascular Graft Division (Terumo Aortic) Hospital Care Solutions Division. Mar 2, 2023 ... Terumo Blood and Cell Technologies, careers in STEM. 354 views · 1 ... Terumo Corporation•3.5K views · 37:39. Go to channel · A Guide of how to .... Since 2012 Terumo has been committed to the UN Global Compact corporate responsibility initiative and its principles in the areas of human rights, labor, the environment, and anti-corruption. Terumo is a constituent of the FTSE4Good Index Series and the FTSE Blossom Japan Index (as of March 31, 2022). Terumo Group’s target for reducing ... Singapore Aug2021 Top view of new unopened terumo medical syringes in carton boxes on table. Somerset, NJ, USA - August 23, 2022: Terumo Medical Corporation ...The objective for a multinational corporation, or any other kind of corporation, is a specific goal that the corporation wants to attain, and it must be something that managers can...Terumo is also actively promoting digital transformation. At regularly held global meetings, the Production Department, part of our corporate functions, introduces effective methods of utilizing digital tools as well as concrete examples of successes with this regard while also providing guidance on introducing image diagnosis systems powered ...Whether you want to file a complaint, ask a question or apply for a job, there are many reasons why you may need to reach a company’s corporate office. While the details for every ... Terumo corporation, 80 Corporate Information Editorial Policy Terumo prepares communication tools to provide stakeholders with straightforward reporting on the business activities it is pursuing in fulfill - ment of its Group mission—“Contributing to Society through Healthcare”—and to promote communication with society. Terumo Reports provide, Mar 7, 2024 ... Terumo Corporation: Delivering Better Quality Care, for Better Patient Outcomes(2024). 14 views · 7 hours ago ...more. Terumo Corporation. 1.6K., A subsidiary of Terumo Corporation, the “No. 1 Medical Device Manufacturer in Japan” with 20 factories and 79 sales branches supplying 150 countries globally. With the mission of contributing to society through healthcare, we produce our innovative products with strict quality assurance system and vast technological expertise and we develop ..., Headquartered on the East Coast of the United States, in New Jersey, Terumo Medical Corporation is the central location for four divisions, notably Terumo Health Outcomes (THO), Terumo Medical Products (TMP), the Pharmaceutical Solutions Division (PSD), and Terumo Interventional Systems (TIS)., Terumo brings solutions of value to medical settings through three companies. Currently, the Terumo Group includes three companies that operate in over 160 countries and regions around the world, providing patients, a variety of medical settings, and the pharmaceutical industry with over 50,000 products and services., Terumo's Response to COVID-19. Education and Training. Business Overview. Business Overview. TIS Division (Terumo Interventional Systems) Neurovascular Division (MicroVention) Cardiovascular Division (Terumo Cardiovascular)/ HeartSheet Division. Vascular Graft Division (Terumo Aortic) Hospital Care Solutions Division., Terumo's Purpose PUSHING BOUNDARIES IN INTERVENTIONAL MEDICINE Terumo Interventional Systems (TIS), a division of Terumo Medical Corporation, is a market leader in minimally invasive entry site management, lesion access, and interventional technologies., Corporate Terumo Blood and Cell Technologies partners with CiRA Foundation to develop automated iPS cell manufacturing iPS cell manufacturing organization researchers to integrate Terumo Blood and Cell Technologies’ Quantum Flex, …, Corporate Terumo Blood and Cell Technologies partners with CiRA Foundation to develop automated iPS cell manufacturing iPS cell manufacturing organization researchers to integrate Terumo Blood and Cell Technologies’ Quantum Flex, …, The Chief Legal Officer (CLO), in cooperation with the compliance officers of the Terumo Group companies who are in charge of promoting compliance related activities, promote a variety of measures including creating related rules, performing training and education, and monitoring to quickly discover and ascertain compliance issues., About Terumo. Terumo (TSE: 4543) is a global leader in medical technology and has been committed to “Contributing to Society through Healthcare” for 100 years. Based in Tokyo and operating globally, Terumo employs more than 30,000 associates worldwide to provide innovative medical solutions in more than 160 countries and regions., Jul 21, 2022 · Terumo India is part of Terumo Corporation, a global leader in medical technology with headquarters in Tokyo, Japan and over 25,000 associates worldwide. Established in 1921 and with its 100 years of history, Terumo’s starting point and unchanging corporate mission has been ‘Contributing to Society through Healthcare.’ , Terumo's Purpose PUSHING BOUNDARIES IN INTERVENTIONAL MEDICINE Terumo Interventional Systems (TIS), a division of Terumo Medical Corporation, is a market leader in minimally invasive entry site management, lesion access, and interventional technologies., 27.00. -1.03%. Find the latest Terumo Corporation (TRUMY) stock quote, history, news and other vital information to help you with your stock trading and investing., Dec 5, 2023 ... This video is part of the "From Devices to Solutions" feature content in the "Technology" section of Terumo's official corporate website,&nb..., Ningún uso de marca registrada, nombre comercial o imagen de Terumo Corporation, Terumo Medical de México S.A. de C.V., en este sitio puede ser utilizado, sin la previa autorización escrita de Terumo Corporation, Terumo Medical de México S.A. de C.V., Need a corporate training service in Canada? Read reviews & compare projects by leading corporate coaching companies. Find a company today! Development Most Popular Emerging Tech D..., As we celebrated our 100th founding anniversary last year, we reconfirmed our Purpose. Building on our base of rock-solid quality, we maximize the latest technology toward advancement of healthcare in order to support each patient’s precious life. This has been the unchanging commitment of Terumo since its founding, as it has advanced along ..., RADIFOCUS™ Guide Wire M Baby-J™ ( 1.5 mm J-Tip ) A nitinol hydrophilic guide wire covered with polyurethane containing tungsten and a hydrophilic Mcoat™ for good torque control and shape memory., The holiday season is just around the corner, and it’s time to start thinking about corporate gifts. If you’re struggling to find the perfect present that will show your appreciati..., Terumo Medical Corporation (TMC) is a subsidiary of Terumo Corporation, founded in 1972 as the United States expansion of our larger Tokyo-based parent. For over 50 years, TMC has continued the Terumo mission of offering the best possible solutions to healthcare providers and the people they serve., Terumo’s Purpose. Terumo's Response to COVID-19. Education and Training. Business Overview. Business Overview. TIS Division (Terumo Interventional Systems) Neurovascular Division (MicroVention) Cardiovascular Division (Terumo Cardiovascular)/ HeartSheet Division. Vascular Graft Division (Terumo Aortic), 1. Bioabsorbable Anchor: Begins to hydrate and soften 24-36 hours after deployment 6 and is absorbed 95% at 42 days 6. 2. Bioabsorbable Collagen: Designed to conform to the arteriotomy for confident closure 2. 3. Bioabsorbable Suture: Tethers the anchor and collagen together, providing a secure seal 2., Cash and cash equivalents at the end of the year. (100M yen) *Figures of each quarter are of the year-to-date results. *Figures are rounded and may have minor differences from the figures in other materials. Financial Highlights. , 1/5/2021 - TOKYO, JAPAN. Terumo Corporation (TSE: 4543) is celebrating its 100 th anniversary this year - marking 100 years of 'Contributing to Society through Healthcare' on September 17, 2021. The company has established 'Stride Ahead' as a slogan, to celebrate and connect all Terumo associates around the world., Clinical Supply Co., Ltd. (Japan), a manufacturer of interventional oncology devices, joins Terumo Group, enhancing Terumo's interventional systems business in the field of radiotherapy. , Terumo | 4,477 followers on LinkedIn. Terumo Group (Global) | Terumo is a global leader in medical technology and has been committed to "Contributing to Society through …, Terumo is a global medical device company originating from Japan. We pursue reliable quality and technology to contribute to healthcare in more than 160 countries and regions around the globe. At Terumo, we reduce patients’ difficulties both mentally and physically, while delivering solutions that help solve various issues in medical settings., TOKYO, JAPAN – May 15, 2023 – Terumo Corporation (TSE: 4543) today announced that it will construct a new manufacturing facility for the Medical Care Solutions Company in the premises of the Kofu Factory located in Yamanashi, Japan. The total investment will be 52.2 billion JPY, and the construction will be completed in fiscal year 2025., Terumo Corporation (Shibuya-ku, Tokyo Japan; CEO Takashi Wachi), a leading provider of general hospital, cardiac and vascular, and home healthcare products, today announced that it has entered into a definitive agreement to acquire MicroVention Inc. (California, USA), a privately held medical device company focused on endovascular coils and related products for the treatment of cerebral aneurysms., Terumo Europe is a core player in the EMEA (Europe, Middle East and Africa) healthcare market by providing best in class quality products and services. We are a strong actor of Terumo Group by contributing to innovation and sustainable growth. We conduct business locally while pursuing a unified EMEA strategy., Terumo Corporation is a manufacturer and supplier of pharmaceuticals and medical tools and equipment. The Company's products include health foods, transfusion and infusion equipment, disposable ..., Terumo's Response to COVID-19. Education and Training. Business Overview. Business Overview. TIS Division (Terumo Interventional Systems) Neurovascular Division (MicroVention) Cardiovascular Division (Terumo Cardiovascular)/ HeartSheet Division. Vascular Graft Division (Terumo Aortic) Hospital Care Solutions Division.